PRECISION BIOSCIENCES INC Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $83.00K, a 40.71% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $78.00K, a 43.07% decline year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $140.00K, a 25.00% increase year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $137.00K, a 31.73% increase year-over-year.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for fiscal 2025 was $218.00K, a 12.45% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for fiscal 2024 was $249.00K, a 32.70% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for fiscal 2023 was $370.00K, a 16.48% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC stock issued during period, value, employee stock purchase plan for fiscal 2022 was $443.00K, a 44.90% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $83.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $218.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-03 | |
| 2025-03-31 | $140.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $249.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $137.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $112.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $370.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $104.00K 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $266.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $443.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $161.00K 10-Q · filed 2022-11-08 | |
| 2022-03-31 | $282.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $804.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $386.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $418.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $640.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $401.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $239.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |